Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers

A pipeline and mucus technology, which is applied in the field of combination formulations of traditional Chinese medicinal materials and amino acids, can solve problems such as large side effects and unsatisfactory effects, and achieve the effects of good therapeutic effect, prolonging human lifespan, and enhancing blood supply.

Inactive Publication Date: 2016-07-06
何松庆
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory in effect and have large side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] 1. 5 grams of Ganoderma lucidum, 7.0 grams of Scrophulariaceae, 0.5 grams of threonine, 0.6 grams of serine, 0.03 grams of cysteine, and 0.03 grams of cystine are made into oral doses, 2 to 4 times a day.

[0030] 2. 2.5 grams of Ganoderma lucidum, 3.5 grams of Scrophulariaceae, 0.25 grams of threonine, 0.3 grams of serine, 0.015 grams of cysteine, and 0.015 grams of cystine are made into oral preparations, 2 to 4 times a day.

[0031] 3. 5 grams of Ganoderma lucidum, 7.0 grams of Scrophulariaceae, 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cysteine ​​are made into oral agents, 2 to 4 times a day.

[0032] 4. 2.5 grams of Ganoderma lucidum, 3.5 grams of Scrophulariaceae, 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cysteine ​​are made into oral agents, 2 to 4 times a day.

[0033] 5. 5 grams of Ganoderma lucidum, 7.0 grams of Scrophulariaceae, 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cystine are made into oral...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The invention uses Ganoderma lucidum, Scrophulariaceae, threonine, serine, cysteine ​​and cystine as a combined formula. Ganoderma lucidum and Scrophulariaceae have the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .

Description

technical field [0001] The invention relates to a combined formula of Chinese medicinal materials and amino acids, belonging to the field of medicines. Background technique [0002] Most human diseases occur or originate in the digestive system and respiratory system, especially inflammatory bowel disease (inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) in the digestive system and chronic bronchitis (chronicbronchitis) in the respiratory system. Asthma (bronchialasthma) and other diseases whose etiology and pathogenesis have not yet been fully clarified. Since the cause and pathogenesis of these diseases have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the course of these diseases. [0003] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. [0004] Medical immunology believes that the immune system has abnormal recognition ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/808A61P1/00A61P11/00A61K31/198A61K36/074
CPCA61K36/074A61K31/198A61K36/808
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com